Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
10/2005
10/13/2005US20050224761 Thermostable and monoconjugatable gold cluster complexes
10/13/2005CA2559948A1 Beta-aminoacid-derivatives as factor xa inhibitors
10/13/2005CA2558615A1 Azabicyclo-octane inhibitors of iap
10/12/2005EP1584625A1 Method of preparing tripeptide intermediates for the preparation of LHRH antagonists
10/12/2005EP1583775A2 Peptide compound containing boron
10/12/2005EP1583713A1 Peptide nanostructures encapsulating a foreign material and method of manufacturing same
10/12/2005EP1583557A2 Vaccine compositions and methods
10/12/2005EP1583526A1 Acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein
10/12/2005EP1049793B1 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
10/12/2005EP0818462B1 Glu-trp comprising tripeptides
10/12/2005CN1681839A Proline ester and preparation containing the same for percutaneous administration
10/12/2005CN1681838A Nogo受体拮抗剂 Nogo receptor antagonist
10/12/2005CN1681517A Peptide boronic acids useful in making salts thereof
10/12/2005CN1681490A Melanin extinguisher
10/12/2005CN1680428A Preparation of alanyl glutamine dipeptide compound
10/12/2005CN1680427A Water soluble piduomode composite salt and its preparation
10/12/2005CN1679919A Intracellular isoform of the interleukin-1 receptor antagonist
10/11/2005US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS
10/11/2005US6953791 Dipeptide derivatives
10/11/2005CA2333875C Redox reversible bipyridyl osmium complex conjugates
10/11/2005CA2333732C Redox reversible imidazole-osmium complex conjugates
10/06/2005WO2005093056A1 Process for producing dipeptide
10/06/2005WO2005092850A1 Amino acid and peptide conjugates of arylalkylic acids for cosmetic use
10/06/2005WO2005092363A1 Preventive/remedy for diabetic complications using oligopeptide
10/06/2005WO2005073216A3 Hcv ns-3 serine protease inhibitors
10/06/2005WO2005069894A3 Conformationally constrained smac mimetics and the uses thereof
10/06/2005WO2004084812A3 Tamandarin analogs and fragments thereof and methods of making and using
10/06/2005US20050222426 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine.
10/06/2005US20050222395 New peptide derivatives
10/06/2005US20050222387 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/06/2005US20050222382 Process for producing sugar peptide having asparagine sugar chain and the sugar peptide
10/06/2005US20050222231 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; nervous system, psychological, and psychiatric disorders
10/06/2005US20050222120 Peptides derivatives comprising thiazepine group for the treatment of hyperlipidermic conditions
10/06/2005US20050222119 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
10/06/2005US20050222093 Methods for restoring cognitive function following systemic stress
10/06/2005US20050222047 Compounds as enzyme inhibitors to treat hepatitis with viricides
10/06/2005US20050222045 Novel derivatives of 2-hydroxytetrahydrofuran and their use as medicaments
10/06/2005US20050222015 Dehydrodidemnin B
10/06/2005US20050222012 Methods and compositions for treating leukemia
10/06/2005US20050221368 Methods for identifying RNA binding compounds
10/06/2005US20050220801 Immunopotentiators
10/05/2005EP1581557A2 Metastin derivatives and their use
10/05/2005EP1581262A2 Contrast agent
10/05/2005EP0775110B1 Arylthio compounds as antibacterial and antiviral agents
10/05/2005CN1678627A Novel depsipeptide compound
10/05/2005CN1678568A Standard compound for immunoassay for dioxin and method of immunoassay for dioxin
10/05/2005CN1676166A Ligand oligopeptide specific combining human epidermal growth factor receptor EGFR
10/04/2005US6951955 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
10/04/2005US6951918 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
10/04/2005US6951850 Dipeptide derivatives
10/04/2005US6951843 Peptide derivatives and their pharmaceutically acceptable salts, thereof, processes for preparation of both and use thereof
10/04/2005US6951839 Methods and compositions for regulating lymphocyte activity
10/04/2005US6951717 Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
10/04/2005US6951682 Porous coatings bearing ligand arrays and use thereof
10/04/2005CA2105304C Inhibitors of human neutrophil elastase and human cathepsin g
09/2005
09/29/2005WO2005090387A2 Histone h2a peptide derivatives and analogs and methods of use thereof
09/29/2005WO2005090386A1 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
09/29/2005WO2005090384A1 Substances k01-0509 and process for producing the same
09/29/2005WO2005090383A2 Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis c viral infections
09/29/2005WO2005090382A1 Antithrombotic compound
09/29/2005WO2005073195A3 Hcv ns-3 serine protease inhibitors
09/29/2005US20050215553 For therapy and prophylaxis of cardiovascular, central nervous system, inflammatory, and bone diseases as well as infectious diseases and certain cancers
09/29/2005US20050215486 Peptidomimetic compounds, useful as antiviral agents
09/29/2005US20050215484 Di-, tri-, and tetra-peptides having antiangiogenic activity
09/29/2005US20050215423 Method of removing transition metals
09/29/2005US20050214943 Transcription factors; nuclear localization peptides; signal sequences; NF-kappaB/Rel proteins; modulating expression of a gene
09/29/2005US20050214853 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
09/29/2005US20050214300 Methods for treating cancer using Porimin as a target
09/29/2005CA2843066A1 Processes and intermediates for the preparation of aspartic acetal caspase inhibitors
09/29/2005CA2559215A1 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
09/29/2005CA2556917A1 Process for preparing macrocyclic compounds
09/29/2005CA2555036A1 Antithrombotic compound
09/29/2005CA2538293A1 Substances k01-0509 and process for producing the same
09/28/2005EP1578931A2 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing an adenosine kinase
09/28/2005EP1578786A2 Heteroaryl peptidomimetics as thrombin receptor antagonists
09/28/2005EP1578777A2 Iap binding compounds
09/28/2005EP1578769A2 Peptides and the use thereof in darkening the skin
09/28/2005EP1578413A2 Ace-inhibitors having antioxidant and no-donor activity
09/28/2005EP1578369A2 Screening strategy for anticancer drugs
09/28/2005EP1000085B1 Treatment of insulin resistance with growth hormone secretagogues
09/28/2005EP0944639A4 Synthetic glycoamines, methods for their use that affect cell
09/28/2005CN1675236A Antibacterial amide macrocycles
09/28/2005CN1675165A Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
09/28/2005CN1674927A Growth hormone releasing peptides
09/28/2005CN1220520C Inhibition of 2, 3-dihydrogen-indone to 26S and 20S prolease
09/27/2005US6949570 Carboxyalkyl substituted sulfonamidomethyl amides or ureas used for treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, and diabetes
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/27/2005US6949516 Oligopeptides used as antiapoptosis agents
09/27/2005US6949515 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases
09/22/2005WO2005087794A1 Process for octreotide synthesis
09/22/2005WO2005087731A1 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005WO2005087730A1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005WO2005087725A2 Novel compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005WO2005087721A2 Compounds as inhibitors of hepatitis c virus ns3 serine protease
09/22/2005WO2005087251A1 Compositions and methods for inhibiting abnormal cell growth
09/22/2005WO2005087250A1 Therapeutic administration of the scrambled anti-angiogenic peptide c16y
09/22/2005WO2003065997A3 Anti-infarction molecules
09/22/2005US20050209308 Coniosulfides and their derivatives, processes for preparing them, and their use as pharmaceuticals
09/22/2005US20050209164 Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
09/22/2005US20050209159 Effectors of dipeptidyl peptidase IV for topical use
1 ... 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 ... 307